Disc Medicine’s leadership tried to express optimism that its rare disease therapy bitopertin can be approved based on a Phase 3 trial set to begin shortly. However, analysts are worried that the ...
By Siddhi Mahatole Feb 17 (Reuters) - Disc Medicine said on Tuesday it will pursue a traditional U.S. approval pathway for ...
The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that been granted expedited review through ...
The FDA in October 2025 granted bitopertin its Commissioner’s National Priority Voucher but after a shortened review time has decided the data did not support regulatory approval for treating ...
By Sneha S K Feb 13 (Reuters) - Disc Medicine said on Friday the U.S. Food and Drug Administration declined to approve its ...
A complete response letter (CRL) was sent by the FDA for Disc's bitopertin for erythropoietic protoporphyria (EPP), which was ...
Disc Medicine received a Complete Response Letter (CRL) from FDA for its New Drug Application (NDA) for bitopertin as a treatment for erythropoietic protoporphyria (EPP), delaying a potential ...
Feb 17 () - Disc Medicine said on Tuesday it will pursue a traditional U. approval pathway for its rare disease drug ...
The PlayStation 5 is finally easy to find after years of scarcity, but before you hit that “add to cart” button, you’ll still have to make an important decision: PS5 Disc or PS5 Digital Edition? And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results